Table of contents
- BPPV Meta-analaysis found no association with low vitamin D in the blood- Oct 2018
- Calcium Carbonate crystals in ear decrease in elderly with low Vit D - April 2018
- Vertigo 23X more likely if vitamin D deficient - Oct 2012
- BPPV reduced 5 X by 50,000 IU IU of vitamin D every 2 weeks - 2016
- BPPV 2.1 X more likely if low vitamin D - Dec 2017
- BPPV much more common with low vitamin D - Oct 2016
- Vertigo eliminated by Vitamin D – April 2019
- Vertigo (BPPV) much more likely to reoccur if low Vitamin D – Feb 2019
- Common cause of dizziness (BPPV) reduced 5 X by several doses of 50,000 IU of vitamin D – 2015, 2016
- Overview Vitamin K and Vitamin D
- Overview Fractures and Falls and Vitamin D
- All items in category Falls or Fractures and Vitamin D
- Search VitaminDWiki for VERTIGO 275 items as of May 2019
- Vitamin D may prevent falls by itself – an overview of 9 meta-analysis – Oct 2012
- Seniors with less than 12 ng of vitamin D were not stable – March 2012
- Overview Magnesium and vitamin D
- Hearing Loss appears to be prevented and treated with vitamin D Hearing loss is strongly associated with Vertigo
- Diseases which are related due to vitamin D deficiency
BPPV associated to Osteoporosis could be added due to the first line of the abstact on this page
- Hypothesis: increased bone mineral density needs protein, Ca, Mg, Vitamin D and K
- Healthy bones need: Calcium, Vitamin D, Magnesium, Silicon, Vitamin K, and Boron – 2012
- VITAMIN D DEFICIENCY SYMPTOMS & VERTIGO LiveStrong July 2012
Vitamin D deficiency and low calcium levels in the ear can lead to inner ear dysfunction that includes hearing loss, tinnitus or vertigo
Your inner ear is partly responsible for your sense of balance, so ear problems may cause dizziness.
Because vitamin D is necessary for calcium absorption, vitamin D deficiency can lead to osteoporosis and calcium loss in the bones of the inner ear
- How I cured vertigo
The short answer: To cure vertigo, drink more water and take magnesium.
- Large Vitamin D website in Germany One of the indications of vitamin D deficiency follows:
Vertigo: I can't see anymore or feel dizzy but I recover when I lie down.
- Vertigo linked to vitamin D deficiency Discussion of this study is behind a $5/month paywall at Vitamin D Counci
Thanks to the Council for pointing out this excellent study
- Vitamin D deficiency and benign paroxysmal positioning vertigo Dec 2012
email@example.com Hypothesis supported by 4 cured cases
- Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo June 2014
Nice abstract, but $40 paywall
- Canalithiasis form of viertigo has lower vitamin D levels than cupulolithiasis form June 2017, 10.1016/j.bjorl.2017.05.007
- The Seasonal Variation of Benign Paroxysmal Positional Vertigo Oct 2016
Association of benign paroxysmal positional vertigo with vitamin D deficiency: a systematic review and meta-analysis
https://doi.org/10.1007/s00405-018-5146-6 7 studies
Conclusion: "Although a negative vitamin D imbalance has been reported among some BPPV patients, this review analysis failed to establish a relationship between the occurrence of BPPV and low vitamin D level. However, low vitamin D level was significantly evident among patients with recurrent episodes of BPPV."
VitaminDWiki: Meta-analysis seems toignore the possibility that there is an OK level of vitamin D in the blood, and that Vitamin D is not getting to the cells of the ear due to poor gene activation.
- "There was a negative correlation between vitamin D and otolin-1 levels of subjects over 70 (r = -0.36, p = 0.036)."
- CONCLUSION: "Our results demonstrate a relationship between vitamin D and otolin-1. The majority of our subjects had abnormally low vitamin D levels, but only those over 70 years of age showed a negative correlation with high otolin-1 levels. We postulate that a seasonal drop in vitamin D may not be sufficient for otoconia fragmentation and ultimately iBPPV, rather, chronically low vitamin D maybe required to induce otoconia degeneration."
Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo - Oct 2012
J Neurol. 2012 Oct 25.
Jeong SH, Kim JS, Shin JW, Kim S, Lee H, Lee AY, Kim JM, Jo H, Song J, Ghim Y.
Department of Neurology, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, Korea.
Previous studies have demonstrated an association of osteopenia/osteoporosis with idiopathic benign paroxysmal positional vertigo (BPPV). Since vitamin D takes part in the regulation of calcium and phosphorus found in the body and plays an important role in maintaining proper bone structure, decreased bone mineral density in patients with BPPV may be related to decreased serum vitamin D. We measured the serum levels of 25-hydroxyvitamin D in 100 patients (63 women and 37 men, mean age ± SD = 61.8 ± 11.6) with idiopathic BPPV and compared the data with those of 192 controls (101 women and 91 men, mean age ± SD = 60.3 ± 11.3) who had lived in the same community without dizziness or imbalance during the preceding year. The selection of the controls and acquisition of clinical information were done using the data from the Fourth Korean National Health and Nutrition Examination Survey, 2008.
The serum level of 25-hydroxyvitamin D was lower in the patients with BPPV than in the controls (mean ± SD = 14.4 ± 8.4 versus 19.1 ± 6.8 ng/ml, p = 0.001). Furthermore, patients with BPPV showed a higher prevalence of decreased serum vitamin D (<20 ng/ml, 80.0 vs. 60.1 %, p < 0.001) than the controls.
Multiple logistic regression analyses adjusted for age, sex, body mass index, hypertension, diabetes, proteinuria, regular exercise and the existence of decreased bone mineral density demonstrated that vitamin D insufficiency (10-20 ng/ml) and deficiency (<10 ng/ml) were associated with BPPV with the odds ratios of 3.8 (95 % confidence interval = 1.51-9.38, p = 0.004) and 23.0 (95 % confidence interval = 6.88-77.05, p < 0.001). Our study demonstrated an association between idiopathic BPPV and decreased serum vitamin D. Decreased serum vitamin D may be a risk factor of BPPV.
VitaminDWiki comment: Perhaps additional possible suspects are low Magnesium and low Vitamin K2
The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study.
Caspian J Intern Med. 2016 Summer;7(3):173-177.
Sheikhzadeh M1, Lotfi Y1, Mousavi A2, Heidari B3, Bakhshi E4.VitaminDWiki
Trail lasted only 8 weeks
Can anticipate much better results if the trial had lasted for 12-16 weeks
Note: Since the average got to 34 ng, we can anticipate that about 40% < 30 ng level of vitamin D
Typically little benefit from vitamin D if < 30 ng
BACKGROUND: Benign paroxysmal positional vertigo (BPPV) is a condition with recurrent attacks in a significant proportion of patients. The present case- control study was conducted to assess the influence of serum vitamin D normalization on recurrent attacks of vitamin D deficient patients.
METHODS: Diagnosis of BPPV was made based on history and clinical examination and exclusion of other conditions. Serum 25-hydroxy vitamin D (25-OHD) was measured using ELISA method and a levels of < 20 ng/ml was considered a deficiency of vitamin D. Inclusion criteria were as follows: history of recurrent attacks and serum 25-OHD<20.ng/ml. While the patients with history of trauma, surgery and chronic systemic diseases were excluded. The patients were classified into two groups: treatment and control, intermittently. Both groups received Epley rehabilitation therapy one session per week for 4 weeks but the treatment group received an additional supplement of 50.000 IU of vitamin D (cholecalciferol) weekly for two months to achieve serum 25-OHD ≥ 30 ng/ml and the study patients were followed-up for 6 months.
RESULTS: Twenty-seven patients were allocated to each group. At baseline, serum 25-OHD was similar (10.7±2.3 vs 11.41±1.9, P=0.23). At month 2, serum 25-OHD in the treatment group increased significantly to ≥ 30 ng/ ml, whereas serum 25-OHD in the control group remained unchanged (34.2±3.3 vs 10.6 10.6±2.2 ng/ml, P=0.001). During the follow-up period, attacks of BPPV in the treatment group decreased significantly compared with the control group (14.8% vs 96.3% OR= 0.18, P=0.001).
CONCLUSION: The findings of this study indicate that the normalization of serum vitamin D significantly reduces BPPV recurrences.
PMID: 27757201 PMCID: PMC5062174
Note: the 2012 study looked at benign paroxysmal positional vertigo
Low 25-hydroxyvitamin D levels in postmenopausal female patients with benign paroxysmal positional vertigo Dec 2017
10.1080/00016489.2017.1416168 Publisher wants $54 for the PDF
Serum vitamin D and recurrent benign paroxysmal positional vertigo.
Laryngoscope Investig Otolaryngol. 2016 Oct 20;1(6):150-153. doi: 10.1002/lio2.35. eCollection 2016 Dec.
OBJECTIVES: The objective of the present study was to examine the effects of serum 25-hydroxyvitamin D concentrations on patients diagnosed with benign paroxysmal positional vertigo (BPPV) on BPPV recurrence.
STUDY DESIGN: Case series.
METHODS: A retrospective review of 232 patients diagnosed with BPPV visiting the clinic between June 2014 and June 2015 was performed. All patients underwent a complete otolaryngological, audiologic, and neurologic evaluation. The appropriate particle-repositioning maneuver was performed depending on the type of BPPV. The patients were divided into the recurrence group and the nonrecurrence group. Age, gender, follow-up period, type of BPPV, and vitamin D concentrations in the two groups were compared and analyzed through binary logistic regression analyses.
RESULTS: The average follow-up period after treatment was 10.2 months. Forty-one (17.7%) of 232 patients suffered a recurrence during the follow-up period. The mean vitamin D concentration of 191 patients who did not suffer any recurrence was 16.63 ng/mL, whereas that of 41 patients who suffered a recurrence was 13.64 ng/mL. This difference in vitamin D concentrations was statistically significant (P < 0.019). The patients' age, gender, follow-up period, and type of BPPV had no statistically significant impact.
CONCLUSION: Vitamin D is assumed to affect BPPV as a recurrence factor independent of age, gender, follow-up period, and type of BPPV.
LEVEL OF EVIDENCE: 4.
PMID: 28894811 PMCID: PMC5510269 DOI: 10.1002/lio2.35
Download the PDF from VitaminDWiki
Possible reasons for association - clipped from PDF
"The authors (of another study) presented two mechanisms of the relationships between BPPV and osteopenia or osteopenia
- First, the decrease of estrogen in reducing the natural regulators of bone mass might disturb the internal structure of the otoconia and/or their interconnection and attachment to the gelatinous matrix.
- Second, an increase of calcium resorption might generate increased concentration of free calcium in the endolymph and reduce its capacity to dissolve the dislodged otoconia."
Vitamin D deficiency and benign paroxysmal positioning vertigo
Journal of Hearing, Balance, and Communication doi.org/10.1080/21695717.2019.1590988
Pedro Jorge Matos Carneiro de Sousa, Diogo Manuel Abreu Pereira, Pedro Carneiro Melo Pereira de Magalhães, Delfim Rui da Silva Duarte & Nuno Maria Trigueiros da Silva Cunha
Download the PDF from Sci-Hub via VitaminDWiki
Treatment group - NO Vertigo
Objectives: Benign paroxysmal positioning vertigo (BPPV) has significant recurrence rates, mainly in older patients. The etiopathology of recurrent BPPV is possibly related to low serum vitamin D levels. Finding a therapeutic weapon will help with these complicated cases, reducing disability, falling risk and also health care costs.
Study design: Clinical trial: one-year duration.
Setting: Ten patients with diagnosis of BPPV made by history and physical examination and at least two episodes of documented BPPV in the previous two years and chronic complaints of dizziness. Neurologic and other otological diseases were excluded for these patients.
Subjects and methods: Vitamin D was evaluated by measuring serum 25-hydroxyvitamin D (25-OHD). Levels below 20 ng/mL were considered deficiency and levels between 20 and 30 ng/mL were considered insufficiency. Half of the patients (treatment group) started a treatment with cholecalciferol while the remaining patients were the control group. All of the patients were reevaluated every three months.
Results: All patients of the treatment group did not have any subsequent episode of positional vertigo, dizziness complaints or nystagmus evoked by provocative manoeuvers. At reevaluations, the mean value of serum 25-OHD for the treatment group had increased noticeably. It was also significantly higher than the mean value of control group. All patients of control group had positional vertigo episodes, as well as positional nystagmus at office reevaluations.
Conclusion: These results support the need to systematically measure and correct vitamin D levels in patients with recurrent BPPV.
New title for this page May 2019. caused the visitor count to reset.
There have actually been
26633 visitors to this page since it was originally made